new post
StocksRunner logo
mail
search
 
menu
 
Coherus BioSciences
$2.30
+6.25%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

CHRS Stock Analysis & IQ Rating | Coherus BioSciences

 
 

CHRS

 

Coherus BioSciences

$2.30

 
+$0.14 | +6.25%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$2.62
 
 
MKT CAP
$277.40M
 
52W Low
$0.71
 
 
VOL
$1.15M
 
P/E Ratio
1.72
 
 
AVG VOL
$2.53M
 
RSI
64.80
 
 
TREND
Uptrend
 
 
 

CHRS Stock IQ

 
lock  Login to see Coherus BioSciences (CHRS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

CHRS Target Price

 
 
 

Strengths

 
 

CHRS Rewards

 Outperform the market

CHRS Rewards

 Upgraded on attractively valued

 
 

CHRS Price Performance

 
 

$1.44   (+59.72%)

$1.57   (+46.50%)

$1.35   (+70.37%)

$1.12   (+105.36%)

 
 
1year
6month
3month
1month
 

CHRS Analysts Opinion

 

Overall standing based on market and analyst consensus. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

CHRS Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

CHRS Future Sentiment

 Outperform the market

 
 

CHRS Analysts Opinion

CHRS Analysts opinion is positive and also has improved from the past 3 months

 

CHRS Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
NA
100%
 

CHRS Street Sentiment 

CHRS Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

CHRS Risk Level

 
 

CHRS has Fair risk level

 
 

Risks Indicators

 Price under $5

 High volatilty

 
 
CHRS Risk Level
Fair
LOW
HIGH
 

CHRS Performance Sentiment

 
Sentiments overview associated with events and the stock performance
 
 
100%
0%
Positive
Negative
5 out of 5
events present
0 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$2.16
 
Resistance
Price
 
$1.36
 
 
Current Price Range
 
$2.51
 
 
Show methods +
 
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Buy
Hold
Sell
 
Consensus Rating

STRONG BUY

1
0
0
 

Date

 

Action

 

Rating

 

Firm

Jan 23, 2026

 

Initiate

 

Outperform

 

Oppenheimer

 
 
 
 
 
CHRS Latest Analysis +
 
 
FAQ About CHRS Stock Insights
 

What is CHRS current stock price?

What are CHRS stock strengths?

What is CHRS Risk Level?

What is CHRS market cap and volume?

What is CHRS current Stock IQ?

Should I buy CHRS stock right now?

Is CHRS a Strong Buy right now?

What does a 'Strong Buy' rating mean for CHRS?

What does a 'Strong Sell' rating mean for CHRS?

What factors influence CHRS's Stock IQ?

 
 
StocksRunner

Explore our CHRS Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CHRS Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CHRS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

CHRS

 

Coherus BioSciences

 
Set Alerts
 
 

Current Price

 

$2.30

 
+$0.14 | +6.25%
 
 
52W High
$2.62
 
 
MKT CAP
$277.40M
 
52W Low
$0.71
 
 
VOL
$1.15M
 
P/E Ratio
1.72
 
 
AVG VOL
$2.53M
 
RSI
64.80
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 

Linked to CHRS

 
 
 
Symbol
Close
Change
 

BIIB

Biogen

178.14

-0.97%

 

AMGN

Amgen

343.86

+0.58%

 

ALVO

Alvotech

5.31

-1.12%

 
 
 
 
 
user
 
 
 
 

CHRS Price Performance

 
 

$1.44   (+59.72%)

$1.57   (+46.50%)

$1.35   (+70.37%)

$1.12   (+105.36%)

 
 
1year
6month
3month
1month
 

CHRS Analysts Opinion

 

Overall standing per market and analyst expectations. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

CHRS Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

CHRS Future Sentiment

 Outperform the market

 
 

CHRS Analysts Opinion

CHRS Analysts opinion is positive and also has improved from the past 3 months

 

CHRS Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
NA
100%
 

CHRS Street Sentiment 

CHRS Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

CHRS Risk Level

 
 

CHRS has Fair risk level

 
 

Risks Indicators

 

 Price under $5

 High volatilty

 
 
CHRS Risk Level
Fair
LOW
HIGH
 
CHRS Performance Sentiment
 
Sentiments overview associated with events and the stock performance.
 
 
100%
0%
Positive
Negative
5 out of 5
events present
0 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$2.16
 
Resistance
Price
 
$1.36
 
 
Current Price Range
 
$2.51
 
 
Show methods +
 
 

Latest Analyst Actions

 

Overall Wall Street Rating

 
 
100%
Buy
Hold
Sell
 
Consensus Rating

STRONG BUY

1
0
0
 
Date
Action
Rating
Firm
 

Jan 23, 2026

Initiate

Outperform

Oppenheimer

 
 
 
 
 
 

CHRS Stock IQ

 
 
 
lock  Login to unlock Coherus BioSciences (CHRS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

CHRS Rewards

 Outperform the market

CHRS Rewards

 Upgraded on attractively valued

 
 
 

CHRS Latest Analysis

 
 
 

Oppenheimer Initiates Coverage of Coherus Oncology (CHRS) with Outperform Recommendation. Fintel reports that on January 22 2026 Oppenheimer initiated coverage of Coherus Oncology (NasdaqGM:CHRS) with a Outperform recommendation. Analyst Price Forecast Suggests 263.52% Upside

 

Fri Jan 23, 2026

$2.06 | +29.56%
 
Potential
Rating

Coherus Oncology a new outperform at Oppenheimer on tagmokitug potential.

 

Fri Jan 23, 2026

$2.06 | +29.56%
 
Potential

Coherus Oncology Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

 

Tue Jan 13, 2026

$1.70 | +3.03%
 
Activity
 
 
 
 
 
StocksRunner

Discover CHRS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CHRS. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CHRS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CHRS Stock trends

CHRS Stock performance

CHRS Stock analysis

CHRS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

CHRS Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CHRS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CHRS

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.